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Background: There is substantial evidence that cognitive therapy is an effective intervention for the treatment of
major depressive disorder. Although dynamic psychotherapies have been widely studied and are commonly
practiced worldwide, there are few randomized comparisons of cognitive therapy and dynamic therapy for major
depressive disorder.
Methods: We are completing data collection on a randomized non-inferiority trial comparing the effectiveness of
cognitive therapy and short-term dynamic psychotherapy in the treatment of major depressive disorder in the
community mental health setting. Therapists employed in the community setting have been recruited for training
in either short-term dynamic psychotherapy or cognitive therapy. Patients seeking services at the community site
who meet criteria for major depressive disorder based on a blind independent diagnostic interview are randomized
to 16 sessions of treatment. All patients are assessed at baseline and months 1, 2, 4, and 5 utilizing a comprehensive
battery.
Discussion: This study adds to the growing literature evaluating the effectiveness of short-term dynamic psychotherapy
for specific diagnostic groups. These results will have implications for the dissemination of effective interventions for major
depressive disorder in community mental health settings.
Trial registration: This trial is registered at ClinicalTrials.gov, a service of the United States National Institute of Health. NIH
Identifier: NCT01207271. Registered 21 September 2010.
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Major depressive disorder (MDD) is a severe and disabling
disorder. Recent estimates of the worldwide prevalence
(current and past month) of MDD is 4.4% (Ferrari et al.
2013). In the United States, approximately 17% of individ-
uals have an MDD episode in their lifetime (Kessler et al.
2005). Data from the Global Burden of Disease study indi-
cates that in the U.S. in 2010, MDD was the fifth ranked
disease/injury in terms of disability adjusted life years (U.S.* Correspondence: gibbonsm@mail.med.upenn.edu
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article, unless otherwise stated.Burden of Disease Collaborators 2013). The pain and
suffering of individuals with depression and those close
to them result in a heavy economic toll to this country
in terms of both treatment costs and lost productivity
(Greenberg et al. 2003).
There is substantial evidence supporting the efficacy of
cognitive therapy (CT; Beck et al. 1979) in the treatment
of MDD. The effects of CT have been shown to be equal
to well-conducted pharmacotherapy (Hollon et al. 1992;
Murphy et al. 1984; Rush et al. 1977; DeRubeis et al. 2005).
In addition, there is evidence that CT has a relapse preven-
tion effect (Evans et al. 1992; Kovacs et al. 1981; Simons
et al. 1986; Hollon et al. 1991; Hollon et al. 2005). In fact,ed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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tion effect that lasted beyond the end of treatment and
was as effective as keeping patients on continued anti-
depressant medication. Finally, benchmarking and effect-
iveness studies have demonstrated that CT is also effective
in real-world practice settings (Persons et al. 1999; Merrill
et al. 2003).
Dynamically oriented psychotherapies have been and
remain widely practiced in the United States and contin-
ental Europe. An international study of over 4000 psycho-
therapists revealed that 35.8% reported their theoretical
orientation as psychodynamic; only an “eclectic” orien-
tation was more common (Heinonen & Orlinsky 2013).
Similarly, among psychologists in the U.S., a psycho-
dynamic approach continues to be the most prevalent
single theoretical orientation (Norcross & Rogan 2013).
Despite the large numbers of practicing psychologists
and psychiatrists using dynamic therapy worldwide, there
are few high quality randomized effectiveness studies
using adequate control conditions, standardized treat-
ments, and well-specified patient populations. Although
a number of studies of dynamic psychotherapy have
been conducted and reviewed (Leichsenring et al. 2014;
Abbass et al. 2014; Leichsenring & Klein 2014; Gerber
et al. 2011; Driessen et al. 2010; Abbass & Driessen
2010; Shedler 2010; Connolly Gibbons et al. 2008; Fonagy
et al. 2005; Leichsenring 2001), very few investigations to
date have met the stringent criteria laid out by Chambless
and Hollon (1998) that have become the gold standard
for defining psychotherapies as evidence-based. Thus,
dynamic therapy for MDD has been characterized as
having only “modest” research support, while CT for
MDD has “strong” research support (Society for Clinical
Psychology, American Psychological Association, Division
12, 2014).
Despite the lack of comparative effectiveness trials com-
paring dynamic therapy to CT, there persists a sense that
dynamic psychotherapy is inferior to CT. In fact, a recent
meta-analysis (Marcus et al. 2014) of 51 psychotherapeutic
investigations concludes that there is consistent evidence
supporting the superiority of CT over dynamically ori-
ented treatments. However, these conclusions are drawn
from only 3 studies that directly compare dynamic therapy
to CT. Giesen-Bloo et al. (2006) found a moderate effect
at 3 years in favor of schema focused therapy over trans-
ference focused psychotherapy in the treatment of border-
line personality disorder. Barkham et al. (1999) found no
difference between 3 sessions of either CT and dynamic
therapy in the treatment of subsyndromal depression.
Finally, Watzke et al. (2012) report an advantage for in-
patient CT over inpatient dynamic therapy using non-
manualized interventions across common mental disorders.
Despite the broad conclusions of the meta-analytic review,
these three investigations hardly warrant the conclusionthat there is consistent evidence of the superiority of CT
and provide no evidence to support the superiority of CT
for MDD specifically.
In regard to MDD, evidence meeting the strict criteria
outlined by Chambless and Hollon (1998) supporting
the effectiveness of short-term dynamic psychotherapy is
beginning to accumulate. Such evidence is critical to
daily clinical decision making and contemporary public
health policy, given that this treatment is so widely prac-
ticed. Two well-designed investigations indicate that
short-term dynamic psychotherapy should be considered
efficacious for MDD in the context of concurrent psy-
chotropic medication usage. Both de Jonghe et al.
(2001) and Burnand et al. (2002) compared combined
dynamic psychotherapy plus antidepressant treatment
to antidepressant treatment alone. Both of these investi-
gations implemented manualized dynamic psychother-
apies (16 sessions in the case of de Jonghe et al. and
10 weeks in the case of Burnand et al.), randomized pa-
tients to treatments, and otherwise used sound experi-
mental methods. Both investigations showed that the
combined short-term dynamic psychotherapy and medica-
tion interventions were statistically superior to medication
alone in the treatment of MDD. These investigations do
not provide us with information regarding the efficacy of
short-term dynamic pychotherapy when implemented
alone, but they do suggest that short-term dynamic psy-
chotherapy for MDD is an effective treatment in the con-
text of medication, a context that is quite common in
current mental health treatment. Further, the Burnand
et al. (2002) investigation implemented a supportive ses-
sion with a nurse in the medication alone condition, indi-
cating that the effects may be due to the specific
interventions of the dynamic treatment rather than the
non-specific relationship effects of a purely supportive
intervention.
More recently, Driessen et al. (2013) have presented
the best evidence to date indicating that short-term dy-
namic psychotherapy should be considered an evidence-
based psychotherapy for MDD. The Driessen et al. (2013)
study, conducted in outpatient clinics in the Netherlands,
was a non-inferiority trial comparing CBT to psycho-
dynamic psychotherapy for 341 patients suffering from
MDD, making it the largest randomized trial of dynamic
psychotherapy for MDD published to date. The results in-
dicate that psychodynamic psychotherapy was not inferior
to CT in the treatment of MDD on measures of depres-
sion severity. Although many have drawn the conclusion
that interventions are equivalent when underpowered
superiority tests have failed to demonstrate statistically
significant differences, this study specifically demon-
strated that dynamic psychotherapy was statistically
significantly non-inferior to CT. Our protocol builds
upon this accumulating evidence. We have conducted a
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CT to short-term dynamic psychotherapy in the treat-
ment of MDD. Like Driessen et al. (2013), this trial was
designed and powered to be a non-inferiority trial. Our
protocol builds on the Driessen et al. (2013) study by
extending outcome assessment beyond the measure-
ment of depression severity to include assessment of
changes in functioning and quality of life and by includ-
ing blind independent ratings of treatment fidelity to
validate that the treatments were implemented in accord-
ance with the treatment manuals and to demonstrate that
the treatments can be distinguished.
An important distinguishing feature of our trial is that
it was conducted in a community mental health setting
in the U.S. In 2008, over 17 million people utilized com-
munity mental health centers (CMHCs). Thirty-five per-
cent of these individuals were insured through Medicaid
and 38% were uninsured (Wells et al. 2010). Thus, CMHCs
provide service to a large number of low-income individ-
uals within the U.S. Compared to results from efficacy tri-
als, the treatment of MDD within the CMHC setting is
less successful. Response rates for pharmacological treat-
ment of MDD in the public sector have been reported to
be less than 30% (Rush et al. 2004). Effective ways of im-
proving the treatment of those with depressive disorders
in CMHCs are therefore sorely needed. Some data on the
effectiveness of CT for MDD in a CMHC setting has
emerged (Merrill et al. 2003), as well as a pilot study of
psychodynamic therapy (Connolly Gibbons et al. 2012),
but no studies comparing different psychotherapies in
the CMHC setting have been conducted to date. The
generalizability of the Driessen et al. (2013) study to a
low-income U.S. CMHC population, which includes a
substantial ethnic minority population, is uncertain. Ef-
forts are currently underway to disseminate CT to
CMHC settings in the U.S., and such training is costly
(Creed et al. 2014). Thus, it is timely to investigate whether
a commonly practiced treatment (psychodynamic therapy)
is inferior to CT in the treatment of MDD in the CMHC
setting.
By conducting our study in a CMHC setting, unlike
many efficacy trials, this trial uses patients seeking treat-
ment and therapists providing services in the community
setting. As such, the study attempts to balance internal
and external validity. Although our clinicians were real
world clinicians working at the community mental health
site, we implemented an intensive yet flexible training pro-
gram at the site to standardize the treatment delivery and
ensure treatment fidelity. In addition, we included patients
seeking treatment at the center and implemented few
exclusion criteria to ensure that the final sample repre-
sented those receiving services in the community. How-
ever, we implemented independent blind expert ratings
of diagnosis and depressive symptoms to ensure that thepatient sample was well-defined and that depressive
symptomatology was reliably and validly assessed.
The primary hypothesis for this trial was that short-
term dynamic psychotherapy would not be inferior to
CT in change in depressive symptoms for patients with
MDD receiving services in a community mental health
setting. Our secondary hypothesis was that short-term
dynamic psychotherapy would not be inferior to CT on
secondary measures of patient-rated symptoms, func-
tioning, and quality of life. We will also investigate the
mechanisms of both CT and short-term dynamic ther-
apy in the context of the randomized trial.Methods
Design
This study is a longitudinal, randomized, non-inferiority
trial being conducted in a large community mental
health clinic. The objective of a non-inferiority trial is to
show that the new or non-established treatment is not
worse than the well-established treatment by more than a
pre-specified non-inferiority margin. This non-inferiority
margin was defined for the current trial as the difference
between the treatment groups that would be considered
the minimum clinically relevant difference. Though most
comparative studies of psychotherapies historically have
used samples of 30–50 participants per treatment group,
non-inferiority studies typically require larger sample sizes
to conclude that one treatment is not inferior to another
within the pre-specified minimal clinically meaningful dif-
ference. The larger sample size of 237 randomized pa-
tients used in the current non-inferiority trial confers an
advantage over previous superiority trials: in addition to
testing for non-inferiority, a separate test is also possible
for superiority, and the study was designed with adequate
statistical power for both tests.Setting: NHS human services
This trial is being conducted through a partnership with
NHS Human Services (NHS), a large, non-profit,
community-based organization that provides services
in seven states with a concentration in the mid-Atlantic
regions. NHS provides a full continuum of behavioral
health services that are clinic and community based for
individuals with mental health and substance abuse disor-
ders and predominantly treats consumers receiving public
assistance for these services. The current study is being
conducted at an outpatient mental health clinic located
just outside of Philadelphia that services approximately
4,900 patients per year and employs 80 outpatient clini-
cians and 3 to 4 full-time psychiatrists. This clinic serves a
racially diverse population with approximately 30% of
those served being African American.
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Patients
Patient participants for the current investigation are be-
ing recruited through the intake department at the out-
patient clinic. A recruitment procedure was developed
to easily identify potential participants utilizing the clinic’s
existing intake procedures while not placing additional
burden on the NHS intake staff who are unable to con-
duct extended diagnostic interviews during intake evalua-
tions due to logistic constraints. Scores from a brief
depression symptom measure, the Quick Inventory for
Depressive Symptomatology (QIDS; Rush et al. 2003), are
used to identify potential study participants. The cutoff
score for being evaluated for the study protocol is 11. The
literature indicates that QIDS scores of 11 or higher are
sensitive to a score of 14 and above on the 17-item
Hamilton Rating Scale for Depression (HAM-D; Hamilton
1960).
All adult patients who present at the clinic for an in-
take appointment complete the QIDS in the waiting
room before their NHS intake assessment. The intake
clinician calculates the total score and asks the patient if
they would be interested in learning more about the re-
search protocol. The intake clinician completes a short
eligibility checklist for patients who scored 11 or higher
on the QIDS, and attaches the checklist to the QIDS
form, which is then collected by a member of the re-
search staff. Eligibility criteria for being evaluated for the
research protocol include 1) a score of 11 or above on
the QIDS, 2) being between 18 and 65 years of age, 3)
ability to read English at the fourth grade level and pro-
vide informed consent, and 4) willingness to be con-
tacted for more information about study participation.
Criteria that exclude patients from the study screening
are 1) current or past diagnosis of schizophrenia, seizure
disorder, psychotic features, and/or clinically significant
organic pathology, 2) significant suicidal risk/ideation
requiring immediate referral for more intensive treat-
ment or specific gesture in the last 3 months, 3) sub-
stance/alcohol abuse symptoms requiring immediate
referral to an intensive substance abuse program, and 4)
pathology requiring referral to a partial hospitalization
program.
After obtaining the forms from the intake department,
a member of the research team reaches out to each re-
ferred patient via a telephone call. At this time, the re-
search staff explains the purpose of the study, asks some
brief screening questions, and schedules an in-person
baseline assessment with interested patients who meet
criteria. All baseline assessments are conducted at the
NHS outpatient clinic. At the assessment, a Bachelor’s-
level research assistant completes informed consent with
the patient and administers the battery of self-report
measures. A blind research diagnostician conducts theStructured Clinical Interview for the DSM-IV Axis I dis-
orders (SCID) interview (First et al. 1997) to determine
eligibility for study participation, and a HAM-D interview
(Hamilton 1960). Patients who meet the following criteria
at the baseline assessment, regardless of other diagnoses,
are excluded from the study: 1) diagnosis of bipolar dis-
order, 2) current or past diagnosis of schizophrenia, seiz-
ure disorder, psychosis, or MDD with psychotic features,
3) depression due to organic pathology, 4) substance/alco-
hol abuse symptoms requiring immediate referral to an in-
tensive substance abuse program, 5) pathology requiring
immediate referral to a partial hospitalization program,
and 6) score of 4 on item #3 of the HAM-D, indicating a
suicidal gesture had occurred in the past week. Patients
who do not meet criteria for the study are immediately re-
ferred back to the intake staff at the site for referral to a
non-study therapist. After completing an informed con-
sent, any patient who receives a current diagnosis of
MDD based on the SCID interview is enrolled either as a
study training case or randomized to a treatment con-
dition. Patients in the randomization phase of the
study are randomly assigned to receive up to 16 ses-
sions across 5 months of weekly individual therapy
with a clinician trained in either short-term dynamic
psychotherapy or CT.
All patients who participate in the protocol receive
$50 gift cards for completion of each of the baseline,
month 1, month 2, and month 5 assessments and a $25
gift card for the briefer month 4 assessment.Clinicians
Clinicians at the Master’s-level and above employed by
NHS are recruited to be trained and treat patients in ei-
ther short-term dynamic psychotherapy or CT for this
study. The research staff advertise the study protocol by
making announcements at staff meetings and placing
fliers in the outpatient clinicians’ mailboxes. Interested
clinicians meet with a member of the research staff and
are enrolled in the training phase of the study if they are
currently seeing adults for outpatient treatment and they
anticipate remaining employed at NHS for the duration
of the project. As an effectiveness trial, all therapists
employed by the center are eligible to enroll in the
study. Therapists are paired with treatment group based
on an evaluation of their past academic training and
supervision, the theoretical identity of the therapist, and
stated desire to be trained in a particular treatment.
Since the majority of therapists have a theoretical orien-
tation consistent with their previous training experiences
and their desired training condition, we decided to
match all therapists to training condition based on their
predominant orientation in order to balance treatment
groups on therapist allegiance to the treatment.
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part of this protocol to date have a variety of training
backgrounds. To be employed at the center, they were
required to have a Master’s degree. Degrees achieved by
the therapists included in the current protocol include:
Master of Arts (M.A.) in Clinical Psychology (n = 1),
M.A. in Counseling Psychology (n = 3), M.A. in Clinical
and Counseling Psychology (n = 2), M.A. in Community
and Clinical Counseling (n = 3), M.A. in Creative Arts in
Therapy (n = 1), M.A. in Health Education (n = 1), Master
of Science (M.S.) in Psychology (n = 1), M.S. in Clinical
Psychology (n = 1), M.S. in Counseling Psychology (n = 1),
M.S. in Clinical and Counseling Psychology (n = 1), M.S. in
Counseling and Clinical Health Psychology (n = 10), M.S. in
Community Counseling (n = 1), M.S. in Experimental
Psychology (n = 1), Master of Social Work (M.S.W.)
(n = 6), Master of Social Service (M.S.S.) (n = 2), Master
of Education (M.Ed.) (n = 1), and Master of Philosophy
in Education (M.Phil.Ed) (n = 1). Three therapists hold
doctorate degrees: Doctor of Philosophy (Ph.D.) in Educa-
tional Psychology (n = 1), Ph.D. in Social Work (n = 1),
and Doctor of Education (Ed.D.) (n = 1).
Procedures
Patients seeking outpatient services at a community
mental health agency are screened for moderate to se-
vere depressive symptoms via self-report at the initial
clinic intake conducted at the center. Figure 1 provides
an outline of patient progress through the study proto-
col. Any patients with moderate to severe depressive
symptoms who are interested in hearing more about the
research program are referred to the research team. A
member of the research team performs a telephone
screen to evaluate the patient’s interest and eligibility
for the study. All interested patients are scheduled
for a research baseline assessment conducted by the
research team at the community mental health center
at the patient’s convenience. Eligible patients are ran-
domized to either short-term dynamic psychotherapy or
CT consisting of 16 weekly outpatient sessions to be
completed within 5 months. All sessions take place at
the CMHC and are conducted by therapists employed at
the center but trained by expert research supervisors.
Patients complete monthly assessments conducted by
the research team at the community mental health
center and meet with a member of the research team
prior to each session to complete some brief self-report
inventories.
Randomization
Patient randomization is performed using a computer
generated randomization algorithm in SAS to assign pa-
tients to the two treatment conditions on a 1:1 basis bal-
ancing across 7 factors. Treatments groups are balancedon gender, race (minority versus white), expectations of
treatment improvement (improvement expected defined
as a rating of greater than or equal to 1 on item 5 of the
Attitudes and Expectations Questionnaire), whether the
patient is taking psychotropic medication at treatment
intake, depression severity (high severity defined as a
score of greater than or equal to 20 on the 17-item
HAM-D versus low defined as a score less than 20), de-
pression recurrence (recurrence defined as 3 or more
episodes of depression including the current episode
based on the SCID interview versus only 1 or 2 epi-
sodes), and relationship status (currently in a long-term
relationship versus not in a relationship).Interventions
Supportive-expressive dynamic psychotherapy
Supportive-expressive dynamic psychotherapy (Luborsky
1984) is a short-term dynamic psychotherapy that fo-
cuses on changes in self-understanding of interpersonal
patterns as one of the main curative factors of psycho-
therapy. Therapists are provided with both the original
manual for supportive-expressive psychotherapy (Luborsky
1984) as well as the supplemental manual elaborating clin-
ical cases (Book 1998). The treatment begins with a number
of techniques designed to build the collaborative relation-
ship, including use of collaborative language (e.g., “we”,
“us”), socialization to treatment including an exploration
of the role of interpersonal patterns in the development of
depressive symptoms, setting specific goals to explore a
particular interpersonal pattern that is currently causing
problems in the patient’s life, and repeated alliance-
building techniques to ensure that the patient and therap-
ist are working together towards a common goal. The
therapist then uses interpretations and clarifications to
help patients elaborate their interpersonal interactions.
The therapist first helps the patient unpack current prob-
lematic interpersonal interactions that contribute to de-
pression using the Core Conflictual Relationship Theme
method (CCRT; Luborsky & Crits-Christoph 1998). The
therapist helps the patient to recognize their wishes and
needs towards the other person, their stereotypic ways of
perceiving the response of the other person towards the
patient, and their own stereotypic ways of responding in
turn within each of the interpersonal interactions. The
therapist then helps the patient to understand the wish
and response patterns that are repetitive across relation-
ships. Once maladaptive interpersonal patterns are identi-
fied, the therapist helps the patient to explore the history
of the interpersonal patterns, to understand their own
contribution to their interpersonal patterns, to explore the
maladaptive nature of their patterns, and to consider alter-
native ways of responding to others to help fulfill their
interpersonal wishes and needs.
All outpatients screened for 
moderate to severe depression 
using QIDS
Research interest assessed by 
clinic intake coordinator
Phone screen conducted by 
research team
Baseline Assessment including 




16 outpatient sessions in 5 months
Dynamic Psychotherapy
16 outpatient sessions in 5 months
Month 1 Follow-up including 
HAM-D and self-report battery
Month 2 Follow-up including 
HAM-D and self-report battery
Month 4 Follow-up including 
HAM-D and self-report battery
Month 5 Follow-up including 
HAM-D and self-report battery
Ineligible if:
• <11 on QIDS
• Intake diagnoses bipolar,  
schizophrenia, seizure disorder, 
psychotic features, or clinically 
significant organic pathology
• Patient reports alcohol/substance 
abuse requiring immediate referral to 
intensive treatment or significant 
suicidal risk
• Patient requires a partial 
hospitalization program Excluded if not interested in research
Ineligible if:
• Patient does not feel depressed 
or is able to enjoy activities 
he/she once enjoyed within the 
past month
• Patient cannot commit to 16 
weeks of therapy
• Patient reports a seizure disorder
• Patient reports psychotic 
features
• Patient has made a suicidal 
gesture within 3 months
Excluded if:
• No current diagnosis of MDD
• Past or current diagnosis of bipolar,
schizophrenia, seizure disorder, 
psychotic features, or clinically 
significant organic pathology
• Patient has substance/alcohol abuse 
symptoms requiring immediate 
referral to intensive treatment
• Patient requires a partial 
hospitalization program
• Patient has made a suicidal gesture 
within 3 months
• Patient receives a score of 2 on item 
12 of SSI or >0 on any item 16-19
and clinic director deems patient 
ineligible for research
Figure 1 Illustration of study design and participant flow.
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The CT is based on the standard text Cognitive Therapy
for Depression (Beck et al. 1979) supplemented with
Cognitive Therapy: Basics and Beyond (Beck 1995). CTconsists of a series of structured sessions which target
behavioral activation and disconfirmation of specific
negative expectations. Standard interventions focus on ac-
tivity scheduling, increasing pleasure/mastery experiences,
Connolly Gibbons et al. BMC Psychology 2014, 2:47 Page 7 of 16
http://www.biomedcentral.com/250-7283/2/47identifying and evaluating automatic thoughts, completing
dysfunctional thought records, and behavioral experi-
ments. As treatment progresses, the emphasis shifts to the
identification and evaluation of more abstract underlying
beliefs and attitudes.
Supervision and training
The design of the supervision and training protocols was
driven by our desire to conduct a real world effective-
ness trial while still maintaining internal validity of the
treatment implementation. Especially for a non-inferiority
trial, it was important that both treatments be imple-
mented with fidelity to the treatment manuals allowing
discrimination based on theoretical differences between
the approaches in order for us to make conclusions about
the non-inferiority of interventions. To balance the
protocol design on the efficacy-effectiveness dimension,
we utilize clinicians already employed at the community
mental health site but use expert supervisors from the
university setting with substantial clinical and research
experience implementing and supervising the treat-
ments. The short-term dynamic psychotherapy super-
visor has been a clinical supervisor at the Center for
Psychotherapy Research at the University of Pennsylva-
nia for the past 20 years as well as a private practitioner
with over 20 years of clinical experience. She has served
as a protocol therapist and as a clinical supervisor for
multiple other federally funded psychotherapy trials of
dynamically oriented psychotherapy. The supervisor for
the CT condition likewise has substantial clinical and
research experience with CT. She has been practicing
CT for 14 years, been responsible for the training of
graduate students in CT, and has participated as a
protocol therapist, and a co-supervisor, in multiple fed-
erally funded investigations of CT.
The training program was developed to be flexible to
the needs of the community clinicians while still including
the intensity of supervision necessary to achieve compe-
tent delivery of the two psychotherapeutic treatments. Fol-
lowing a thorough informed consent process, all clinicians
are asked to read the training manuals and then attend an
initial eight hour in-person training workshop with their
research supervisor, a doctoral-level expert clinician in ei-
ther supportive-expressive dynamic psychotherapy or CT.
Workshops are delivered in 1 full day format, split across
2 sessions, or individualized into multiple sessions to meet
the needs of each training cohort. The workshops are con-
ducted at the clinical site or at the university research set-
ting based on the preferences of the training therapists in
each cohort.
After this initial workshop training, we include both
intensive individual supervision across the first three
cases as well as bimonthly group supervisions through-
out the study to help therapists maintain what they havelearned and continue to increase their therapeutic skills
within the two treatment modalities. Clinicians receive
one hour of individual supervision with their study clin-
ical supervisor for every two sessions of psychotherapy
delivered across each of their first three study patients.
A clinician becomes eligible to treat patients in the ran-
domized phase of the study after they complete at least
eight sessions of treatment with two different training
cases. The majority of the individual supervision is con-
ducted via the telephone, with in-person meetings ar-
ranged occasionally based on the request of the supervisor
and clinician. Throughout the duration of the study, all
clinicians participate in one hour of group supervision
with their research supervisor and fellow clinicians in their
condition twice a month. The group supervisions have
been conducted in person at the community mental
health site across the first two months of training for each
cohort until the supervisor decides they are ready to meet
via teleconference.
All psychotherapy sessions are digitally recorded. Super-
visors listen to at least every other psychotherapy session
for each of the first three cases for each therapist to pre-
pare for the intensive individual supervision. Additionally,
supervisors listen to selected sessions from the randomized
cases throughout the study to prepare for group supervi-
sion sessions. All individual and group supervision sessions
focus on the review of audiotaped sessions. This protocol
was also designed to be flexible to the needs of community
clinicians with a variety of training backgrounds and expe-
riences. The supervisor and clinician can request add-
itional cases of intensive individual supervision to help a
therapist achieve competence. Additional intensive individ-
ual supervision has been requested and conducted by the
supervisors for two therapists in training in short-term dy-
namic psychotherapy and for two therapists in training in
CT to date. Clinicians are reimbursed $300 for the initial
training workshop and $25 for each hour of both individ-
ual and group supervision. For every two study patients
who attend at least one treatment session with a given
clinician, the clinician is awarded a $150 honorarium.
Unlike traditional efficacy studies, the therapist train-
ing has been conducted in waves throughout the 5 years
of the study protocol in parallel to the randomization
phase. In the community mental health setting, therapist
turnover is high and many therapists do not remain
employed at the same site for more than a few years. For
this reason we trained an initial cohort of therapists dur-
ing the first year, and then train yearly cohorts in each
treatment condition in preparation for therapist attri-
tion. Each new training cohort attends separate work-
shops and group supervision sessions until the intensive
individual supervision phase is completed. At that point
therapists can be rolled into ongoing group supervision
groups based on the discretion of the supervisor.
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has been high with the majority of therapists discontinu-
ing the study because they were ending employment at
the site. Across the 5 years of study enrollment, 22 cog-
nitive therapists and 20 dynamic therapists have been
invited to participate in a training workshop. The 22
cognitive therapists completed the workshop; 18 of the
20 dynamic therapists attended the workshop. Following
the workshop, 18 cognitive therapists and 17 dynamic
therapists completed intensive supervision with at least
1 training case. Of these, 9 CT therapists and 11 dy-
namic therapists completed the intensive supervision
and have seen at least 1 patient as part of the random-
ized protocol. The 6 dynamic therapists who left the
study during the training left for a variety of reasons, in-
cluding: 3 that did not have time for the intensive yet
flexible supervision schedule, 1 did not want to continue
the supervision, and 2 that were satisfied with the train-
ing and study but left employment at NHS. Similarly, 3
CT therapists discontinued during training because they
were too busy, 3 did not feel comfortable with the super-
vision, 1 felt that CT was not a good match, 1 was dis-
continued by NHS, and 1 left employment at the site.
Fidelity
We assess adherence and competence of both the CT
and short-term dynamic interventions in order to evaluate
the fidelity with which the interventions are administered
and to confirm that treatments can be discriminated as
practiced in the community mental health setting. Four
advanced graduate students with training in CT have been
recruited to rate adherence and competence of CT. Four
additional advanced graduate students with training in dy-
namic psychotherapy are employed to rate adherence and
competence to short-term dynamic psychotherapy. All
judges have been trained to reliability across 4 training
cases and continue with monthly recalibration sessions to
maintain inter-rater reliability. One session from each pa-
tient from the early sessions of treatment (usually session
3) is rated by 3 judges using a balanced incomplete block
design. The CT judges rate sessions from all CT cases and
a random selection of 20 cases from the dynamic condi-
tion. Alternatively, the trained dynamic judges rate a ses-
sion from all short-term dynamic cases and a random
selection of 20 cases from the CT condition. All judges
complete ratings independently and are blind to the study
design.
For adherence and competence to short-term dynamic
therapy, we are using an adaptation of the Adherence/
Competence Rating Scale for Supportive Expressive
Dynamic Psychotherapy (Barber & Crits-Christoph
1996) specifically adapted to the community friendly
dynamic intervention utilized in the current investiga-
tion (Connolly Gibbons et al. 2012). Items representingthe techniques included in the supportive expressive
model are rated on a 7-point scale for adherence de-
fined as how frequently an intervention was used, and
are rated on a 7-point competence scale representing
how well the intervention is implemented.
For fidelity ratings of CT, the trained independent
judges are using both the CT subscale of the Collaborative
Study Psychotherapy Rating Scale (Hill et al. 1992) to rate
therapist adherence to CT techniques and the Cognitive
Therapy Scale (Vallis et al. 1986) to measure competence
in delivering CT interventions.
Measures
Overview
All participants complete a baseline diagnostic and HAM-D
interview conducted by a trained advanced graduate student
research diagnostician blind to the study design as well
as a comprehensive battery of self-report measures cov-
ering demographic characteristics, treatment expecta-
tions, depressive symptoms, functioning, quality of life,
interpersonal problems, trauma history, and alcohol and
substance use. All participants also complete monthly
assessments at months 1, 2, 4, and 5 consisting of a HAM-D
interview and the self-report battery. At monthly assess-
ments, the research diagnosticians are blind to treatment
condition and number of sessions of treatment attended.
In addition, patients complete measures of mechanism
of change at the months 1, 2, and 5, including measures of
dysfunctional attitudes, compensatory skills, depressotypic
schemas, and self-understanding of interpersonal patterns.
Patients complete the 24-Item Behavior and Symptom Iden-
tification Scale (BASIS-24; Eisen et al. 2004) and the Beck
Depression Inventory-II (BDI-II; Beck et al. 1996) prior to
each session, the measure of alliance following sessions 2, 4,
6, 8, and the measure of treatment credibility after session 2.
A summary of the assessment battery is provided in Table 1.
Quick Inventory of Depressive Symptomatology-Self-Report
(QIDS)
The QIDS (Rush et al. 2003) is a 16-item, self-report
measure designed to assess the severity of depressive
symptoms using the criterion symptoms designated by
the DSM-IV. The QIDS has demonstrated good internal
consistency (Cronbach’s α = .86) in patients with chronic
major depression (Rush et al. 2003). In this same sample,
total scores on the QIDS were highly correlated (r = .81)
with the 17-item HAM-D (Rush et al. 2003).
The Structured Clinical Interview for DSM-IV (SCID)
The SCID-I (First et al. 1997) for DSM-IV was used to
diagnose MDD. For MDD, the kappa coefficient ranges from
.61-.93 (Lobbestael et al. 2011; Segal et al. 1995; Skre et al.
1991; Williams et al. 1992; Zanarini & Frankenburg, 2001;
Zanarini et al. 2000).
Table 1 Summary of study measures
Study variables Assessment point Measurement scale Reference
Diagnosis
Depression Baseline Quick Inventory for Depressive Symptomatology (QIDS), 16 items, α= .86 Rush et al. 2003
Depression Baseline Structured Clinical Interview (SCID) for the DSM-IV First et al. 1997
Clinical characteristics
Demographics Baseline Demographic Questionnaire Developed for current study
Alcohol/substance use Baseline Alcohol Use Disorders Identification Test (AUDIT), 10 items, α = .83 Hays et al. 1995
We developed 6 items to evaluate substance use, adapted from the AUDIT
Trauma history Baseline Traumatic Life Events Questionnaire (TLEQ), 24 items Kubany et al. 2000
Treatment expectations Baseline Attitudes and Expectations (AAE), 14 items Adapted from Elkin et al. 1989
Symptoms
General mental health Baseline, M1, M2, M4, M5, T1-
16
Behavior and Symptom Identification Scale (BASIS-24), 24 items, α= .77-.91 Eisen et al. 2004
Depression Baseline, M1, M2, M4, M5, T1-
16
Beck Depression Inventory–II (BDI-II), 21 items, α = .91 Beck et al. 1996
Depression Baseline, M1, M2, M4, M5 Hamilton Rating Scale for Depression (HAM-D), 27 items, α = .79 Hamilton, 1960; Trajkovic et al. 2011
Functioning/broader outcome
Life satisfaction Baseline, M1, M2, M4, M5 Quality of Life Inventory (QOLI), 32 items, α = .77-.89 Frisch et al. 1992
General functioning Baseline, M1, M2, M4, M5 The Medical Outcomes Study 36-item Short-Form (SF-36), 36 items, α= .78-.94 Ware & Sherbourne 1992; McHorney et al. 1994
Interpersonal problems Baseline, M1, M2, M4, M5 Inventory of Interpersonal Problems (IIP-48), 48 items, α = .69-.80 Gude et al. 2000
Therapeutic process
Therapeutic alliance T2, T4, T6, T8 Working Alliance Inventory–Client (WAI-C), 12 items, α = .93 Horvath & Greenberg 1989
Treatment credibility T2 Opinions About Treatment (OAT), 3 items, α = .90 Adapted from Borkovec & Nau 1972; Mooney et al.
2013
Therapeutic mechanism
Dysfunctional attitudes Baseline, M1, M2, M5 Dysfunctional Attitudes Scale (DAS), 40 items, α = .86 Weissman & Beck 1978; De Graaf et al. 2009
Compensatory skills Baseline, M1, M2, M5 Ways of Responding–Community (WOR-C), α = .72-.79 Adapted from Barber & DeRubeis 1992; Connolly
Gibbons et al. 2014
Ways of Responding–Self-Report (WOR-SR), 65 items, α= .94-.96
Self-understanding Baseline, M1, M2, M5 Self-Understanding of Interpersonal Patterns Scale–Revised (SUIP-R), 28 items,
α = .92
Connolly Gibbons et al. 2009
Underlying depressogenic
schemas
Baseline, M1, M2, M5 Psychological Distance Scaling Task (PDST), 80 items Dozois & Dobson 2001
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The HAM-D (Hamilton 1960) is a widely used inventory
for evaluating the severity of common symptoms of
depression. The 24-item version of the HAM-D was
completed by applying the Structured Interview Guide to
enhance reliability (Williams 1988). A recent meta-analysis
reports a Cronbach’s alpha of .79, as well as good inter-
rater and test-retest reliability (Trajkovic et al. 2011).
The 24-Item Behavior and Symptom Identification Scale
(BASIS-24)
The BASIS-24 (Eisen et al. 2004) is a 24-item self-report in-
ventory designed to measure mental health status from the
consumer’s point of view. The items cover six domains in-
cluding: depression/functioning, interpersonal relationships,
psychotic symptoms, alcohol/drug use, and emotional labil-
ity. The measure has demonstrated acceptable test-retest
reliability and internal consistency and good construct and
discriminant validity (Eisen et al. 2004). Further studies have
supported the reliability, concurrent validity, and sensitivity
of the BASIS-24 in specific racial groups (Eisen et al. 2006).
Beck Depression Inventory-II (BDI-II)
The BDI-II (Beck et al. 1996) is a 21-item, self-report
questionnaire designed to assess recent depressive symp-
toms. The measure demonstrates high internal consistency
(α = .92) and adequate convergent and discriminant validity
(Beck et al. 1996).
Quality of Life Inventory (QOLI)
The QOLI (Frisch et al. 1992) is a 32-item self-report
measure which first rates the importance of something
in a person’s life, such as money or self-esteem, and then
rates how satisfied a person is with this item. The meas-
ure demonstrates good internal consistency (α = .77-.89)
and good convergent validity with seven other measures
of well-being and life satisfaction. The QOLI also dem-
onstrates good test-retest reliability (r = .80-.91) (Frisch
et al. 1992).
The Medical Outcomes Study 36-Item Short Form (SF-36)
The SF-36 (Ware & Sherbourne, 1992) is a widely used
standardized, generic self-report of health status for
evaluating physical and mental health-related quality of
life. The SF-36 consists of 36 items; 35 of the items
group into eight multi-item scales that collectively meas-
ure health-related quality of life (Physical Functioning,
Role Limitations due to Physical Health Problems, Bodily
Pain, General Health Perceptions, Vitality, Social Func-
tioning, Role Limitations due to Emotional Problems, and
Mental Health), and the remaining item concerns the ex-
perience of change in general health during the last year.
The measure demonstrates good internal consistency for
each of the eight scales, with Cronbach’s alpha rangingfrom .78 for General Health Perceptions to .93 for Physical
Functioning (McHorney et al. 1994).
Pretreatment expectations
To assess pretreatment expectations we utilize one item
from an unpublished measure (Moras & Jones 1992)
adapted from the National Institute of Mental Health
Treatment of Depression Collaborative Research Program
(Elkin et al. 1989). The item asks participants to rate the
question, “How much improvement do you expect to ex-
perience as a result of treatment,” on a 7-point Likert scale
ranging from “-3” (I expect to feel much worse) to “3” (I
expect to feel much better). The use of the single item
measure of pretreatment expectations has been widely
used in previous studies and has shown validity in predict-
ing therapeutic alliance (Connolly Gibbons et al. 2003)
and treatment credibility (Mooney et al. 2013).
Treatment credibility form: Opinions About Treatment (OAT)
This questionnaire is administered early in the treatment
to obtain the patient's opinion of the probable value of
the treatment he/she is receiving for his/her problems. It
will be used to determine whether the treatment ap-
proaches are equal in credibility. The OAT (Borkovec &
Nau 1972) demonstrates high internal consistency (α = .90)
(Mooney et al. 2013).
The Inventory of Interpersonal Problems-48 (IIP-48)
This 48-item self-report measure helps to identify
sources of interpersonal distress. It describes both the
types of interpersonal problems that people experience
and the level of distress associated with them and can
be used to measure interpersonal changes over the
course of therapy. The IIP-48 (Gude et al. 2000) measures
Assertiveness, Sociability, and Interpersonal Sensitivity. It
demonstrates good internal consistency (α = .69-.80) and
high correlation with the original 127-item IIP (Horowitz
et al. 1988).
Working Alliance Inventory–Client (WAI-C)
This 12-item self-report form measures the quality of
the alliance between the therapist and the patient from
the point of view of the patient. The WAI-C (Horvath
& Greenberg 1989) demonstrates high internal consistency
(α = .93) and good convergent validity with the Counselor
Rating Form (CRF; LaCrosse & Barak 1976) and the
Empathy Scale of the Relationship Inventory (RI; Barrett-
Lennard 1962).
Traumatic Life Events Questionnaire (TLEQ)
This 24-item questionnaire assesses exposure to a broad
range of potentially traumatic events and provides a brief
trauma history of the patient. When events are endorsed,
respondents are asked if they experienced intense fear,
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temporal stability, discriminant validity, and construct val-
idity across all subscales (Kubany et al. 2000).
Alcohol Use Disorders Identification Test (AUDIT)
This test was developed as a screening instrument for
hazardous and harmful alcohol consumption. It is a 10-
item questionnaire which covers the domains of alcohol
consumption, drinking behavior, and alcohol-related prob-
lems. The research team constructed a parallel assessment
of substance use also covering consumption, behavior, and
substance-related problems. The AUDIT (Saunders et al.
1993) demonstrates good internal consistency (α = .83) and
acceptable convergent validity with the CAGE alcohol
screen (r = .62) and the Michigan Alcoholism Screening
Test (MAST) (r = .66) (Hays et al. 1995).
Dysfunctional Attitudes Scale (DAS)
The DAS (Weissman & Beck 1978) is a 40-item in-
strument that is designed to identify and measure cogni-
tive distortions, particularly distortions that may relate
to or cause depression. The items contained on the DAS
are based on Beck’s cognitive therapy model and present
7 major value systems: Approval, Love, Achievement,
Perfectionism, Entitlement, Omnipotence, and Autonomy.
The measure demonstrates good internal consistency
(α = .86) and acceptable convergent validity. Depressed
individuals score significantly higher on both Perfectionism
and the 17-item total than their non-depressed counter-
parts. Further, the Perfectionism score and 17-item total
score correlate more highly with depression severity than
with dependency (De Graaf et al. 2009).
Ways of Responding–Community (WOR-C)
We adapted the Ways of Responding (WOR; Barber &
DeRubeis 1992) for use in the community mental health
setting. The WOR is a 6-item essay response question-
naire which measures compensatory skills through mood
inductions. After each mood induction scenario is pre-
sented, the subject writes how he or she would respond in
the given situation. The WOR-C (Connolly Gibbons et al.
2014) was adapted from the WOR by developing depressive
scenarios that were more applicable to the community
population. The WOR-C demonstrated good reliability
and convergent validity with the original WOR and other
measures of depressotypic thinking in both student nor-
mal and clinical samples (Connolly Gibbons et al. 2014).
Four graduate student judges have been trained to
categorize each thought unit provided by the patient
into a set of possible depressotypic cognitive behavioral
responses or compensatory cognitive skills across 4 train-
ing sessions held via teleconference. Three judges are
assigned to blindly rate each patient scenario using a bal-
anced incomplete block design. While ratings are beingcompleted, monthly recalibration sessions are used to pre-
vent rater drift.
Ways of Responding–Self–Report (WOR-SR)
The WOR-SR (Connolly Gibbons et al. 2014) is a 65-item
measure adapted from the WOR modifying the measure
to capture compensatory skills using a self-report Likert
scale format. The WOR-SR demonstrated good internal
consistency reliability and convergent validity in both stu-
dent normal and clinical samples (Connolly Gibbons et al.
2014).
Psychological Distance Scaling Task (PDST)
The PDST (Dozois & Dobson 2001) is a measure of
cognitive organization that captures underlying depres-
sogenic schemas. On this task, a square grid is presented
to subjects on a computer monitor. In the middle of this
grid is a horizontal line, anchored with the statement
Not at all like me on the left and Very much like me on
the right. A vertical line is also shown in the middle of
the grid with the anchors Very positive at the top and
Very negative at the bottom. The subject is presented
with 80 different adjectives (one at a time) in the center
of the grid, and respondents are instructed to move the
mouse to the position on the screen that best character-
izes the degree of self-relevance and degree of valence of
the word.
Self-Understanding of Interpersonal Patterns-Revised
(SUIP-R)
The SUIP-R (Connolly Gibbons et al. 2009) is a 28-item
self-report instrument that measures a client’s level of
understanding of his or her interpersonal patterns. The
self-understanding score represents each patient’s level
of self-understanding of those interpersonal conflicts
that are relevant in his/her world. Self-understanding is
defined across a continuum ranging from recognition of
an interpersonal conflict within a specific situation, to
recognition of the pervasiveness of the pattern, the his-
tory of the pattern, one’s own contribution to the pat-
tern, and finally to the ability to recognize and then
reevaluate the pattern at the time it is experienced. The
SUIP-R has demonstrated good internal consistency,
convergent validity, sensitivity to change, and ability to
discriminate change in dynamic psychotherapy com-
pared to other therapeutic conditions (Connolly Gibbons
et al. 2009).
Diagnosticians
Nine advanced graduate students in clinical psychology
have been hired by the research team to conduct the SCID
and HAM-D interviews. All diagnosticians are blind to
the treatment conditions being implemented in the proto-
col as well as all study hypotheses. The diagnosticians are
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pointments and conduct all assessments in person at the
community mental health center. Training procedures for
diagnosticians are tailored to each diagnostician’s entry
skill level. All diagnostic training has been conducted and
supervised by a master’s-level clinician with substantial ex-
perience conducting both SCID and HAM-D interviews
as well as substantial experience training diagnosticians to
competence. The diagnostic training procedure has five
components: (a) a training workshop with the diagnostic
supervisor to review diagnostic procedures; (b) rating
SCID master training tapes prepared by Miriam Gibbon,
M.S.W., and Michael First, M.D., of New York State Psy-
chiatric Institute and reviewing ratings with the diagnostic
supervisor; (c) rating audiotapes of diagnostic interviews
conducted by experienced diagnosticians to obtain a pre-
liminary estimate of the reliability with which the new
diagnostician interprets SCID-obtained data as evidence
for DSM diagnostic criteria; (d) conducting a diagnostic
interview on a mock patient and reviewing the results
with the diagnostic supervisor; and (e) conducting 2 train-
ing interviews at the community site with extensive review
and feedback from the diagnostic supervisor. All diagnos-
tic training interviews are conducted on training cases for
the current protocol. Diagnostic interviews for random-
ized cases are only conducted by diagnosticians who have
completed these training steps and are deemed competent
by the diagnostic supervisor. The diagnostic supervisor
then conducts monthly group conference calls with all di-
agnosticians to review problems, questions, and concerns.
These conferences are further used to review a diagnostic
interview with the diagnosticians to maintain reliability.
Finally, the expert diagnostician conducts a random re-
view of 10% of the audiotapes of diagnostic interviews and
provides written feedback to the diagnostician to prevent
drift.
Study progress
This study began enrollment on October 10th, 2010 and
the target enrollment of 237 patients was completed on
July 2nd, 2014. This study was powered to randomize
230 patients to the two treatment condition, estimating
that 203 patients would have at least one post baseline
assessment. To date we have randomized 237 patients to
the two treatments and have 208 patients with at least
one post-baseline assessment. Recruitment for this proto-
col has closed with 7 patients still engaged in active treat-
ment and 16 patients still due for follow-up assessments.
Data collection is expected to be completed by December,
2014.
Statistical analysis
Preliminary data analyses will include descriptive statistics
and exploratory graphing such as frequencies, means,standard deviations, box and whisker plots, stem and
leaf diagrams, and scatter plots to assess the normality
of the data in terms of the presence of skew and/or
outliers for both the outcomes and adherence scores. If
necessary, the continuous outcome data will be trans-
formed by using an appropriate transformation such as
the log transformation for skewed, long-tailed data.
Hypothesis 1: short-term dynamic psychotherapy will be not
inferior to CT on change from baseline to endpoint of acute
treatment in the HAM-D total score
This hypothesis is formulated in terms of a non-inferiority
test, which is a one-sided equivalence test. The non-
inferiority margin will be established to be smaller than
any clinically relevant change and will be based on the
recommendation for this provided by McHorney et al.
(1994) and previously implemented in a non-inferiority
study of treatments for MDD (Szegedi et al. 2005): a
non-inferiority margin of 2.5 HAM-D total score points
(this is the difference in change from baseline to end-
point between the two treatment groups). Standard de-
viation of change scores on the HAM-D are not
typically reported in published studies, but standard de-
viations from two large studies of CT ranged from 6.4
(from Dimidjian et al. 2006) to 6.8 (DeRubeis et al.
2005). However, one published study of medication for
MDD found a standard deviation of 8.5 (Szegedi et al.
2005). Although the studies with CT groups had lower
standard deviations, these studies were not done in
community settings where variability would be expected
to be higher. Thus, to be conservative, we will use the
higher figure (8.5) from the Szegedi et al. (2005) study.
Based on the 8.5 standard deviation of HAM-D total
score change scores, the 2.5 HAM-D points corresponds
to a Cohen’s d effect size of 0.29.
We expect that some patients will fail to complete the
study. We will implement pattern mixture models to as-
sess the randomness of the “completion” process. If the
process is random, we will implement the modified two
one-sided test approach for equivalence discussed by
Lee et al. (2005), who discussed a maximum likelihood
statistical procedure for analyzing equivalence trials with
missing observations.
Secondary analyses will also be conducted using the
mixed effects model to test for slope differences between
treatment groups in the HAM-D. The mixed effects
modeling is used to account for the clustering structure
of the data (i.e., repeated assessments within an individual)
and is implemented with the SAS Mixed Procedure of the
SAS 9.1.3 software. We will implement a mixed-model
analysis of variance (MMANOVA). The MMANOVA
does not assume any specific profile/pattern between
the outcome variable and time, but rather focuses on the
average separation between groups across the treatment
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and assess the average outcome between groups across
the post-baseline monthly assessments. The MMANOVA
is similar to a repeated measures analysis of variance
model, but offers flexibility to deal with missing data and
modeling the variance-covariance matrix of the outcome
(Schwarz 1993).
All modeling structures allow for important covariates.
We will include any baseline measures which differ be-
tween groups. The impact of gender and minority status
on any treatment effects will also be explored in second-
ary analyses.
Hypothesis 2: short-term dynamic psychotherapy will be not
inferior to CT on change from baseline to endpoint of acute
treatment on secondary measures of symptoms,
patient functioning, and quality of life
Analyses of the secondary outcome measures will be
conducted as non-inferiority analyses as described above
for the primary outcome measure. For the secondary
analyses, we will use the BASIS-24 total score, the
Physical Component Summary and the Mental Compo-
nent Summary of the SF-36, as well as the total score
from the QOLI. Because there is no consensual defin-
ition of a minimally clinically significant difference on
these other measures, we will set the non-inferiority
margin to be the same effect size (d =0.29) used for the
HAM-D. We will also conduct analyses using the mixed
effects model to test for slope differences between treat-
ment groups on each of the secondary outcome mea-
sures, with only the number of assessments varying
depending on the measure.
Ethics statement
All study procedures are being conducted in compliance
with the Institutional Review Board of the University of
Pennsylvania.
Data Safety Monitoring Board (DSMB)
A DSMB was appointed to monitor the progress of the
study, review data quality, and evaluate patient safety issues
as they arise. The committee consists of three scientists
who are independent of the study.
Discussion
The results of this investigation will supplement the
growing body of literature evaluating the effectiveness of
short-term dynamic psychotherapy for the treatment of
MDD. This trial builds on the non-inferiority trial pub-
lished by Driessen et al. (2013) by extending the com-
parison of CT and short-term dynamic psychotherapy to
the U.S. community mental health setting utilizing pri-
marily clinicians with master’s degrees, by going beyondsymptom outcomes to include both patient functioning
and quality of life, and by implementing blind and inde-
pendent adherence/competence ratings to ensure the
treatments were delivered with fidelity. To date, there is
substantial evidence indicating that CT is an efficacious
intervention for the treatment of MDD. Our results
should add to the literature evaluating whether short-
term dynamic psychotherapy might also be considered
an efficacious alternative intervention for the treatment
of MDD in the CMHC setting.
This trial also has limitations that should be considered
in evaluating the results. The design as a non-inferiority
trial has the significant advantage of allowing us to evalu-
ate whether the treatments are statistically equivalent in
effectiveness. By comparing the effects of short-term dy-
namic psychotherapy to an already established treatment,
we can evaluate the equivalence of these treatments in
practice. However, our design did not include a control
condition to control for the passage of time. In addition,
our study generalizes to the community mental health set-
ting. Although it is useful to study the comparability of
these treatments in the real world of treatment delivery, it
is possible that the results will not generalize to other
practice settings.
In conclusion, this randomized non-inferiority trial
will add to our understanding of the effectiveness of
short-term dynamic psychotherapy as a treatment alter-
native for MDD. This research focus could have implica-
tions for the dissemination of interventions for the
treatment of MDD in the real world. To date, tremen-
dous efforts and resources have been spent retraining
therapists and disseminating CT for the treatment of
MDD despite the fact that many therapists practicing
worldwide describe themselves as dynamically oriented.
The comparability of these treatments for MDD in real
world practice should be considered in dissemination
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